UK Metabolic Disorder Therapeutics Market Size & Outlook
The metabolic disorder therapeutics market in UK is expected to reach a projected revenue of US$ 8,121.5 million by 2030. A compound annual growth rate of 10.1% is expected of UK metabolic disorder therapeutics market from 2025 to 2030.
Revenue, 2024 (US$M)
$4,626.6
Forecast, 2030 (US$M)
$8,121.5
CAGR, 2025 - 2030
10.1%
Report Coverage
UK
Related Markets
UK metabolic disorder therapeutics market highlights
- The UK metabolic disorder therapeutics market generated a revenue of USD 4,626.6 million in 2024 and is expected to reach USD 8,121.5 million by 2030.
- The UK market is expected to grow at a CAGR of 10.1% from 2025 to 2030.
- In terms of segment, diabetes was the largest revenue generating disease in 2024.
- Lysosomal Storage Diseases is the most lucrative disease segment registering the fastest growth during the forecast period.
Metabolic disorder therapeutics market data book summary
| Market revenue in 2024 | USD 4,626.6 million |
| Market revenue in 2030 | USD 8,121.5 million |
| Growth rate | 10.1% (CAGR from 2025 to 2030) |
| Largest segment | Diabetes |
| Fastest growing segment | Lysosomal Storage Diseases |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Lysosomal Storage Diseases, Diabetes, Obesity, Inherited Metabolic Disorders, Hypercholesterolemia, Other Metabolic Diseases |
Other key industry trends
- In terms of revenue, UK accounted for 6.0% of the global metabolic disorder therapeutics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK metabolic disorder therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 8,121.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metabolic Disorder Therapeutics Market Scope
Metabolic disorder therapeutics market segmentation & scope
Lysosomal Storage Diseases
Inherited Metabolic Disorders
Hypercholesterolemia
Diabetes
Obesity
Other Metabolic Diseases
Cellular Transplantation
Drug Therapy
Enzyme Replacement Therapy
Small Molecule Based Therapy
Substrate Reduction Therapy
Gene Therapy
Metabolic Disorder Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BioMarin | View profile | - | - | - |
| Novo Nordisk A/S | View profile | - | - | - |
| Biocon | View profile | 10001+ | Bangalore, Karnataka, India, Asia | http://www.biocon.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
UK metabolic disorder therapeutics market size, by disease, 2018-2030 (US$M)
UK Metabolic Disorder Therapeutics Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
